Leonteq Securities AG’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-840
Closed -$73.5K 1318
2021
Q4
$73.5K Hold
840
﹤0.01% 834
2021
Q3
$68.7K Sell
840
-52
-6% -$4.68K ﹤0.01% 793
2021
Q2
$81.4K Sell
892
-460
-34% -$41K ﹤0.01% 761
2021
Q1
$116K Buy
1,352
+512
+61% +$45.9K 0.01% 653
2020
Q4
$79.3K Buy
+840
New +$73.4K ﹤0.01% 716

Other funds holding NVS

Leonteq Securities AG's NVS Position: Q1 2022 in Review

Leonteq Securities AG sold out of Novartis (NVS) in Q1 2022, closing a stake of 840 shares — an estimated $73.5K sold.

Leonteq Securities AG first reported a position in NVS in Q4 2020 and held it in 5 quarters. The position peaked at $116K in Q1 2021. 1,136 funds tracked by Wall St. Rank hold NVS as of Q1 2022.

  • Leonteq Securities AG reported no remaining Novartis position as of Q1 2022 after selling out during the quarter.
  • Leonteq Securities AG sold 840 Novartis shares in Q1 2022, an estimated $73.5K.
  • Leonteq Securities AG first reported a position in Novartis in Q4 2020 and held it in 5 quarters.
  • Leonteq Securities AG's Novartis position peaked at $116K in Q1 2021.
  • 1,136 funds tracked by Wall St. Rank held Novartis as of Q1 2022.

Based on Leonteq Securities AG's 13F filing for Q1 2022, filed 26 Mar 2026.